# The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

> **NCT07592754** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Neuromyelitis Optica Spectrum Disease (NMOSD)

## Interventions

- **BIOLOGICAL:** KSVCBD injection

## Key facts

- **NCT ID:** NCT07592754
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-03-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07592754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07592754, "The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT07592754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*